Literature DB >> 7485327

The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

P J Meis1, R L Goldenberg, B Mercer, A Moawad, A Das, D McNellis, F Johnson, J D Iams, E Thom, W W Andrews.   

Abstract

OBJECTIVE: Our purpose was to evaluate the association of bacterial vaginosis, trichomonas vaginitis, and monilial vaginitis with spontaneous preterm birth at < 35 weeks 0 days. STUDY
DESIGN: A total of 2929 women at 10 centers were studied at 24 and 28 weeks' gestation by Gram stain of vaginal smear, wet mount, and 10% potassium hydroxide preparations to detect vaginal infections.
RESULTS: The rates of detected infection at 24 and 28 weeks, respectively, were bacterial vaginosis 23.4% and 19.4%, trichomonas 3.3% and 2.7%, and monilia 21.1% and 19.5%. The occurrence of bacterial vaginosis at 28 weeks was associated with an increased risk of spontaneous preterm birth, odds ratio 1.84 (95% confidence interval 1.15 to 2.95, p < 0.01). Detection of Trichomonas vaginalis (by wet mount) or monilia (by potassium hydroxide preparation) had no significant associations with preterm birth.
CONCLUSION: The presence of bacterial vaginosis at 28 weeks' gestation is associated with an increased risk of spontaneous preterm birth.

Entities:  

Mesh:

Year:  1995        PMID: 7485327     DOI: 10.1016/0002-9378(95)91360-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  95 in total

Review 1.  Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Authors:  Ronald F Lamont; Chia-Ling Nhan-Chang; Jack D Sobel; Kimberly Workowski; Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

Review 2.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

Review 3.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

4.  Midtrimester bacterial vaginosis and cervical length in women at risk for preterm birth.

Authors:  Melissa S Mancuso; Dana Figueroa; Jeff M Szychowski; Merri Maddox Paden; John Owen
Journal:  Am J Obstet Gynecol       Date:  2010-12-22       Impact factor: 8.661

5.  Prevalence and comparison of diagnostic methods for Trichomonas vaginalis infection in pregnant women in Argentina.

Authors:  Beatriz E Perazzi; Claudia I Menghi; Enrique F Coppolillo; Claudia Gatta; Martha Cora Eliseth; Ramón A de Torres; Carlos A Vay; Angela M R Famiglietti
Journal:  Korean J Parasitol       Date:  2010-03-18       Impact factor: 1.341

6.  Candida Vulvovaginitis in Pregnancy.

Authors:  Jinping Xu; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

Review 7.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

8.  Vaginal symptoms and bacterial vaginosis (BV): how useful is self-report? Development of a screening tool for predicting BV status.

Authors:  D B Nelson; S Bellamy; A Odibo; I Nachamkin; R B Ness; L Allen-Taylor
Journal:  Epidemiol Infect       Date:  2007-02-05       Impact factor: 2.451

Review 9.  Preterm birth due to maternal infection: Causative pathogens and modes of prevention.

Authors:  M V Pararas; C L Skevaki; D A Kafetzis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

10.  Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery.

Authors:  Herbert Kiss; Ljubomir Petricevic; Peter Husslein
Journal:  BMJ       Date:  2004-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.